Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is one of the more commonly reported side effects of tirzepatide, noted across the SURMOUNT clinical programme and reflected in the NHS tirzepatide medicines page. It tends to peak in the first few weeks of treatment or after a dose increase, and for most people it settles as the body adjusts. If you are feeling unusually tired on Mounjaro, the evidence points to a handful of practical steps — eating enough protein, staying well hydrated, protecting sleep, and pacing activity — that can make a real difference. Mounjaro is a prescription-only medicine; a prescriber assesses your suitability and reviews side effects as part of the clinical process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the SURMOUNT-1 trial (2,539 adults, 72 weeks) fatigue was among the adverse events recorded across all tirzepatide doses, though it was more frequent in the active-treatment groups than placebo. The NHS tirzepatide page lists tiredness as a common side effect, meaning it affects roughly 1 in 10 or more people. That context matters: tiredness on Mounjaro is real, it is recognised, and it does not mean something is going wrong, and our detailed guide to tirzepatide and fatigue explains why these responses happen at a physiological level.
Two mechanisms seem to drive it. First, tirzepatide slows gastric emptying and suppresses appetite significantly, so total calorie intake drops. The body, running on less fuel than it is used to, can feel sluggish. Second, the adjustment period after starting or increasing a dose involves shifts in gut hormones that affect energy regulation more broadly. Both effects are front-loaded: most people find they are worst in the week or two after a change in dose, then ease off.
What this means practically is that the timing of fatigue is diagnostic. If you feel most tired in the 48–72 hours after your weekly injection and it gradually lifts, that pattern fits the pharmacokinetic profile of tirzepatide well. If tiredness is constant and getting worse week on week, that warrants a conversation with your prescriber rather than a self-management strategy. You can read more about how the fatigue pattern tends to unfold on our page on how long Mounjaro fatigue typically lasts.
A question our prescribers hear most weeks: "I'm eating so much less, is that why I'm exhausted?" Usually, yes, partly. Tirzepatide's appetite suppression is effective enough that some people unintentionally eat too little protein, which accelerates muscle breakdown and compounds fatigue. Aiming for 1.2–1.6 g of protein per kilogram of body weight each day is a practical target supported by the NHS England weight-management injections guidance on maintaining lean mass during treatment. Eggs, Greek yoghurt, chicken, fish, pulses, sources that also provide slow-release energy.
Hydration is the other lever people overlook. GLP-1 medicines can cause nausea and vomiting, and even mild fluid loss affects cognitive sharpness and physical energy noticeably. The practical fix is boring but effective: small amounts of water regularly through the day rather than large volumes infrequently. Electrolyte-containing drinks (low-sugar versions) can help if nausea has been interfering with eating and drinking.
Meal timing also plays a role. Because gastric emptying is slower on tirzepatide, eating a large meal close to bedtime can disrupt sleep quality and leave you feeling unrefreshed. Shifting the larger meal earlier in the day and keeping the evening meal lighter is a simple adjustment that many people find helpful. For constipation that is adding to your lethargy, fibre and fluid are the first response, see our guide to managing constipation from Mounjaro for specifics.
Fatigue and poor sleep create a feedback loop. Tirzepatide can improve sleep quality over time (particularly in people with obstructive sleep apnoea, a condition it is licensed to treat alongside weight management) but the early adjustment period can temporarily disrupt it. Keeping a consistent sleep schedule, limiting caffeine after mid-afternoon, and avoiding screens in the hour before bed are not novel suggestions, but they are the ones with the clearest evidence base.
On exercise: some people, feeling tired, stop moving altogether. That tends to make fatigue worse rather than better. Moderate-intensity activity (a 20-minute walk rather than a gym session) supports mitochondrial function and mood, both of which affect perceived energy. The key word is moderate. During weeks when fatigue is peaking, this is not the time to push through a heavy strength session. Protect the habit; adjust the intensity. Resistance work matters for preserving lean mass during weight loss, but even two sessions a week of light to moderate resistance is enough to make a difference.
If you want a fuller picture of how fatigue fits into tirzepatide's overall side-effect profile, the Mounjaro side effects overview covers the broader pattern, and our dedicated page exploring whether Mounjaro causes fatigue goes deeper on the mechanism.
Most tiredness on Mounjaro is benign and self-limiting. Some patterns are not. Contact a healthcare professional promptly if you experience fatigue alongside severe or persistent abdominal pain (especially pain that radiates towards the back) with or without vomiting. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines specifically highlighted acute pancreatitis as an infrequent but serious risk, and that combination of symptoms is the key warning sign.
Also seek medical advice if you feel faint or dizzy rather than simply tired, if you have not been able to keep fluids down for more than 24 hours, or if you notice any sudden change in vision. These can point to dehydration, low blood pressure, or, in people who also take diabetes medication, hypoglycaemia, all of which need assessment rather than self-management.
Persistent fatigue that does not fit the post-injection pattern and does not improve after several weeks should also be reviewed, and our full guide to Mounjaro fatigue covers the range of factors worth discussing with your prescriber. A prescriber may want to check thyroid function, iron stores, or other causes that are unrelated to tirzepatide but can co-exist with it. At nume, our prescribers discuss side effects like fatigue as a standard part of the clinical review, every repeat order is assessed individually, never rubber-stamped. If you have questions about whether Mounjaro is right for you, check your eligibility through a free consultation. You can also learn more about the service and how our clinical team works on the about us page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.